Third Rock Ventures
 | |
| Industry | Venture capital |
|---|---|
| Founded | 2007 |
| Headquarters | Boston, Massachusetts, United States |
| Website | thirdrockventures |
Third Rock Ventures is a healthcare venture capital firm founded in 2007.[1] Since its inception, the firm has invested in more than 65 biotechnology companies, which have collectively brought more than 20 products to market.[2]
Approach
[edit]Third Rock maintains an active discovery pipeline, where members of the firm identify and advance projects across a range of therapeutic areas, including oncology, cardiovascular disease, rare diseases and more.[2] In addition to the firm’s discovery projects, Third Rock invests in initial financing rounds for external companies.
Third Rock is highly engaged in its ventures, and the firm’s partners frequently serve as interim leaders in portfolio companies when launched. This approach allows the firm to guide the companies’ early operational and strategic decisions.[3]
Funding and investments
[edit] | This section contains promotional content. (January 2024) |
Third Rock Ventures’ closed its sixth and most recent fund in 2022, raising $1.1 billion.[4] This brings the total funds raised by the firm to $3.8 billion.[2]
Boilerplate
[edit]Third Rock Ventures is a leading healthcare venture firm focused on advancing disruptive areas of science and medicine to deliver breakthroughs to patients. By starting with big ideas and fostering collaboration among people with expertise in science, medicine, business and strategy, we aim to discover, launch and build innovative companies that can transform the lives of patients. Our mission is to be the preferred partner for entrepreneurs, investors, employees and industry to build great companies that discover and develop products that make a difference for the patients we serve.[5]
References
[edit]- ^ "Third Rock Ventures". MIT Technology Review. Retrieved 2024-11-12.
- ^ a b c Terry, Mark (June 15, 2022). "In Tough Biotech Market, Third Rock Raises New $1.1B Fund". BioSpace.
- ^ "Approach". Third Rock Ventures.
- ^ Aragon, Lawrence (2022-06-13). "Third Rock rolls up $1.1bn for sixth fund". Venture Capital Journal. Retrieved 2024-11-12.
- ^ "Third Rock Ventures Expands Senior Team with Seasoned Biotech Executives". BusinessWire. January 25, 2024. Retrieved November 12, 2024.
External links
[edit]
 | This United States corporation or company article is a stub. You can help Wikipedia by expanding it. |